Sacral neuromodulation: long term outcome and quality of life in patients with faecal incontinence

Ö Uludag, J. Melenhorst, S.M. Koch, W.G. van Gemert, C.H.C. Dejong, C.G.M.I. Baeten

Research output: Contribution to journalArticleAcademicpeer-review

24 Citations (Scopus)

Abstract

Aim Since 1994 sacral neuromodulation (SNM) has increasingly been used for the treatment of faecal incontinence, but no long-term data in a large group of patients have so far been published. We report long-term outcome and quality of life in the first 50 patients treated by permanent SNM for faecal incontinence.

Method We began to use SNM in 2000. Data from the first 50 patients with faecal incontinence who underwent permanent SNM are presented. Efficacy was assessed using a bowel diary and the Quality of Life score was assessed by the Faecal Incontinence Quality of Life questionnaire (FIQOL) and the standard short form health survey questionnaire (SF-36).

Results Over a median follow up of 7.1 (5.6-8.7) years, forty-two (84%) patients had an improvement in continence of over 50%. Median incontinent episodes and days of incontinence per week decreased significantly during follow up (P <0.002). Improvement was seen in all four categories of the FIQOL scale and in some domains of the SF-36 QOL questionnaire. There were no statistically significant changes in the median resting and squeeze anal canal pressures.

Conclusion Initial improvement in continence with SNM was sustained in the majority of patients, with an overall success rate of 80% after a permanent implant at 7 years.

Original languageEnglish
Pages (from-to)1162-1166
Number of pages5
JournalColorectal Disease
Volume13
Issue number10
DOIs
Publication statusPublished - Oct 2011

Keywords

  • Quality of life
  • sacral neuromodulation
  • sacral neurostimulation
  • faecal incontinence
  • NERVE-STIMULATION
  • REPAIR
  • MULTICENTER
  • PREVALENCE
  • THERAPY

Cite this

@article{4039a84edb8c4104bcefd250f93508cf,
title = "Sacral neuromodulation: long term outcome and quality of life in patients with faecal incontinence",
abstract = "Aim Since 1994 sacral neuromodulation (SNM) has increasingly been used for the treatment of faecal incontinence, but no long-term data in a large group of patients have so far been published. We report long-term outcome and quality of life in the first 50 patients treated by permanent SNM for faecal incontinence.Method We began to use SNM in 2000. Data from the first 50 patients with faecal incontinence who underwent permanent SNM are presented. Efficacy was assessed using a bowel diary and the Quality of Life score was assessed by the Faecal Incontinence Quality of Life questionnaire (FIQOL) and the standard short form health survey questionnaire (SF-36).Results Over a median follow up of 7.1 (5.6-8.7) years, forty-two (84{\%}) patients had an improvement in continence of over 50{\%}. Median incontinent episodes and days of incontinence per week decreased significantly during follow up (P <0.002). Improvement was seen in all four categories of the FIQOL scale and in some domains of the SF-36 QOL questionnaire. There were no statistically significant changes in the median resting and squeeze anal canal pressures.Conclusion Initial improvement in continence with SNM was sustained in the majority of patients, with an overall success rate of 80{\%} after a permanent implant at 7 years.",
keywords = "Quality of life, sacral neuromodulation, sacral neurostimulation, faecal incontinence, NERVE-STIMULATION, REPAIR, MULTICENTER, PREVALENCE, THERAPY",
author = "{\"O} Uludag and J. Melenhorst and S.M. Koch and {van Gemert}, W.G. and C.H.C. Dejong and C.G.M.I. Baeten",
year = "2011",
month = "10",
doi = "10.1111/j.1463-1318.2010.02447.x",
language = "English",
volume = "13",
pages = "1162--1166",
journal = "Colorectal Disease",
issn = "1462-8910",
publisher = "Wiley",
number = "10",

}

Sacral neuromodulation: long term outcome and quality of life in patients with faecal incontinence. / Uludag, Ö; Melenhorst, J.; Koch, S.M.; van Gemert, W.G.; Dejong, C.H.C.; Baeten, C.G.M.I.

In: Colorectal Disease, Vol. 13, No. 10, 10.2011, p. 1162-1166.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Sacral neuromodulation: long term outcome and quality of life in patients with faecal incontinence

AU - Uludag, Ö

AU - Melenhorst, J.

AU - Koch, S.M.

AU - van Gemert, W.G.

AU - Dejong, C.H.C.

AU - Baeten, C.G.M.I.

PY - 2011/10

Y1 - 2011/10

N2 - Aim Since 1994 sacral neuromodulation (SNM) has increasingly been used for the treatment of faecal incontinence, but no long-term data in a large group of patients have so far been published. We report long-term outcome and quality of life in the first 50 patients treated by permanent SNM for faecal incontinence.Method We began to use SNM in 2000. Data from the first 50 patients with faecal incontinence who underwent permanent SNM are presented. Efficacy was assessed using a bowel diary and the Quality of Life score was assessed by the Faecal Incontinence Quality of Life questionnaire (FIQOL) and the standard short form health survey questionnaire (SF-36).Results Over a median follow up of 7.1 (5.6-8.7) years, forty-two (84%) patients had an improvement in continence of over 50%. Median incontinent episodes and days of incontinence per week decreased significantly during follow up (P <0.002). Improvement was seen in all four categories of the FIQOL scale and in some domains of the SF-36 QOL questionnaire. There were no statistically significant changes in the median resting and squeeze anal canal pressures.Conclusion Initial improvement in continence with SNM was sustained in the majority of patients, with an overall success rate of 80% after a permanent implant at 7 years.

AB - Aim Since 1994 sacral neuromodulation (SNM) has increasingly been used for the treatment of faecal incontinence, but no long-term data in a large group of patients have so far been published. We report long-term outcome and quality of life in the first 50 patients treated by permanent SNM for faecal incontinence.Method We began to use SNM in 2000. Data from the first 50 patients with faecal incontinence who underwent permanent SNM are presented. Efficacy was assessed using a bowel diary and the Quality of Life score was assessed by the Faecal Incontinence Quality of Life questionnaire (FIQOL) and the standard short form health survey questionnaire (SF-36).Results Over a median follow up of 7.1 (5.6-8.7) years, forty-two (84%) patients had an improvement in continence of over 50%. Median incontinent episodes and days of incontinence per week decreased significantly during follow up (P <0.002). Improvement was seen in all four categories of the FIQOL scale and in some domains of the SF-36 QOL questionnaire. There were no statistically significant changes in the median resting and squeeze anal canal pressures.Conclusion Initial improvement in continence with SNM was sustained in the majority of patients, with an overall success rate of 80% after a permanent implant at 7 years.

KW - Quality of life

KW - sacral neuromodulation

KW - sacral neurostimulation

KW - faecal incontinence

KW - NERVE-STIMULATION

KW - REPAIR

KW - MULTICENTER

KW - PREVALENCE

KW - THERAPY

U2 - 10.1111/j.1463-1318.2010.02447.x

DO - 10.1111/j.1463-1318.2010.02447.x

M3 - Article

VL - 13

SP - 1162

EP - 1166

JO - Colorectal Disease

JF - Colorectal Disease

SN - 1462-8910

IS - 10

ER -